At National Tay-Sachs & Allied Diseases Science Symposium, Leading Neurodegenerative Disease Researchers Present Breakthroughs

New developments in crossing the blood-brain barrier bring human trials closerBOSTON, MA—April 6, 2011—Breakthroughs in crossing the blood-brain barrier could lead to new treatments for Tay-Sachs, Canavan and other neurodegenerative diseases.  The findings were presented Thursday at the National Tay-Sachs & Allied Diseases  (NTSAD) Science Symposium by leading researchers working together to find a treatment. New methods of delivering missing enzyme to the brain show improvement in animal studies. Human trials may begin as soon as next year for Tay-Sachs, one of